← Back to opportunities

A Health Economic Evaluation Framework And Bespoke Analysis For AMR Diagnostic Technologies

MEDICINES DISCOVERY CATAPULT LIMITED

Buyer Contact Info

Buyer Name: MEDICINES DISCOVERY CATAPULT LIMITED

Buyer Address: Block 35g, Mereside Alderley Park, Macclesfield, UKD62, SK10 4ZF, United Kingdom

Contact Email: procurement@md.catapult.org.uk

Status
active
Procedure
open
Value
300000.0 GBP
Gross: 360000 GBP
Published
12 Nov 2025, 12:21
Deadline
09 Dec 2025, 16:00
Contract Start
n/a
Contract End
n/a
Category
services
CPV
73000000 - Research and development services and related consultancy services
Region
n/a
Awarded To
n/a
Official Source
Open Find a Tender

Description

PACE (Pathways to Antimicrobial Clinical Efficacy) is a £30 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders in the UK's health innovation and research community. The PACE programme is looking for an external provider to deliver an 'Enabling Project' in partnership related to early health economic analysis to support our cohort of AMR diagnostic innovation developers from our 2nd PACE funding call. Please see (https://paceamr.org.uk/news/ukhsa-announced-as-first-pace-collaboration-to-help-tackle-deadly-antimicrobial-resistance/) for details of our first enabling project partnering with UKHSA to provide access to clinical isolates for our first cohort of therapeutics developers. The overall purpose of this second enabling project is to provide PACE awardees and the wider AMR community with access to practical early-stage health economic outputs, including care pathway insights, indicative cost analyses, early-stage economic modelling and value proposition frameworks tailored to our cohorts emerging diagnostic technologies. These outputs will be designed to support product development decisions, stakeholder engagements and future reimbursement planning with relevance across bloodstream infections (BSI), respiratory tract infections (RTI) and urinary tract infections (UTI). To maximise impact, the provider is expected to group diagnostics with similar clinical positioning or use cases together to make the most of synergies across the cohort (e.g. when establishing the existing care pathway of the indications). Where relevant, the provider is also expected to align with existing or ongoing initiatives. A key priority is to ensure that insights, and findings from the project are made publicly available through open-access tools, share reports etc. to ensure that it benefits the broader AMR innovation community to inform future policy, funding and procurement decisions. The support required is across three work packages: Kick-off webinar: Introduce PACE awardees (diagnostics projects) to early-stage health economic assessment including its purpose, relevance and application across the cohort. Baseline development and modelling tool: Deliver care-pathway analyses (BSI, RTI and UTI) and a re-usable (modelling with guidance -enabling scenario testing using default assumptions. Project-specific deployment: Collaborate with each PACE project to input diagnostic specific data, generate tailored analyses, and refine the tool using real-world examples.

Linked Documents

No linked documents found for this notice.

Opportunity Context

More Information Links

External Link: https://www.find-tender.service.gov.uk/Notice/073147-2025

Link Description: Tender notice on Find a Tender

Lots

Lot 1 Status: active

Lot 1 Value: GBP 300,000

Lot 1 Value (Gross): GBP 360,000

Lot 1 Contract Start: 2026-02-09T00:00:00Z

Lot 1 Contract End: 2027-08-08T23:59:59+01:00

Lot 1 SME Suitable: Yes

Lot 1 Award Criterion (quality): Quality (80%)

Lot 1 Award Criterion (price): Price (20%)

Documents

Document Description: Not published

Document Description: Tender notice on Find a Tender

Raw Notice JSON

Expand raw payload
{
  "buyer": {
    "id": "GB-COH-09928547",
    "name": "MEDICINES DISCOVERY CATAPULT LIMITED"
  },
  "date": "2025-11-12T12:21:39Z",
  "id": "073147-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05df7e",
  "parties": [
    {
      "additionalIdentifiers": [
        {
          "id": "PJPQ-6911-DQYY",
          "scheme": "GB-PPON"
        }
      ],
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Macclesfield",
        "postalCode": "SK10 4ZF",
        "region": "UKD62",
        "streetAddress": "Block 35g, Mereside Alderley Park"
      },
      "contactPoint": {
        "email": "procurement@md.catapult.org.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ]
      },
      "id": "GB-COH-09928547",
      "identifier": {
        "id": "09928547",
        "scheme": "GB-COH"
      },
      "name": "MEDICINES DISCOVERY CATAPULT LIMITED",
      "roles": [
        "buyer"
      ]
    }
  ],
  "tag": [
    "tenderUpdate"
  ],
  "tender": {
    "aboveThreshold": true,
    "amendments": [
      {
        "description": "Added the link to the Proactis advert to assist suppliers in accessing the opportunity - https://procontract.due-north.com/Advert?advertId=d32c4542-afbf-f011-813a-005056b64545",
        "id": "073147-2025"
      }
    ],
    "awardPeriod": {
      "endDate": "2026-02-09T23:59:59Z"
    },
    "description": "PACE (Pathways to Antimicrobial Clinical Efficacy) is a \u00a330 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders in the UK\u0027s health innovation and research community.\nThe PACE programme is looking for an external provider to deliver an \u0027Enabling Project\u0027 in partnership related to early health economic analysis to support our cohort of AMR diagnostic innovation developers from our 2nd PACE funding call. Please see (https://paceamr.org.uk/news/ukhsa-announced-as-first-pace-collaboration-to-help-tackle-deadly-antimicrobial-resistance/) for details of our first enabling project partnering with UKHSA to provide access to clinical isolates for our first cohort of therapeutics developers.\nThe overall purpose of this second enabling project is to provide PACE awardees and the wider AMR community with access to practical early-stage health economic outputs, including care pathway insights, indicative cost analyses, early-stage economic modelling and value proposition frameworks tailored to our cohorts emerging diagnostic technologies. These outputs will be designed to support product development decisions, stakeholder engagements and future reimbursement planning with relevance across bloodstream infections (BSI), respiratory tract infections (RTI) and urinary tract infections (UTI).\nTo maximise impact, the provider is expected to group diagnostics with similar clinical positioning or use cases together to make the most of synergies across the cohort (e.g. when establishing the existing care pathway of the indications). Where relevant, the provider is also expected to align with existing or ongoing initiatives. A key priority is to ensure that insights, and findings from the project are made publicly available through open-access tools, share reports etc. to ensure that it benefits the broader AMR innovation community to inform future policy, funding and procurement decisions.\nThe support required is across three work packages:\nKick-off webinar: Introduce PACE awardees (diagnostics projects) to early-stage health economic assessment including its purpose, relevance and application across the cohort.\nBaseline development and modelling tool: Deliver care-pathway analyses (BSI, RTI and UTI) and a re-usable (modelling with guidance -enabling scenario testing using default assumptions.\nProject-specific deployment: Collaborate with each PACE project to input diagnostic specific data, generate tailored analyses, and refine the tool using real-world examples.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      },
      {
        "datePublished": "2025-11-12T12:21:39Z",
        "description": "Tender notice on Find a Tender",
        "documentType": "tenderNotice",
        "format": "text/html",
        "id": "073147-2025",
        "noticeType": "UK4",
        "url": "https://www.find-tender.service.gov.uk/Notice/073147-2025"
      }
    ],
    "enquiryPeriod": {
      "endDate": "2025-11-26T16:00:00Z"
    },
    "id": "ocds-h6vhtk-05df7e",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Research and development services and related consultancy services",
            "id": "73000000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "country": "GB",
            "countryName": "United Kingdom",
            "region": "UK"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "name": "Quality",
              "numbers": [
                {
                  "number": 80,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "name": "Price",
              "numbers": [
                {
                  "number": 20,
                  "weight": "percentageExact"
                }
              ],
              "type": "price"
            }
          ]
        },
        "contractPeriod": {
          "endDate": "2027-08-08T23:59:59+01:00",
          "maxExtentDate": "2028-02-08T23:59:59Z",
          "startDate": "2026-02-09T00:00:00Z"
        },
        "hasRenewal": true,
        "id": "1",
        "renewal": {
          "description": "The PACE programme will have the option to extend the Contract for a further 6 months, subject to the awarded Suppliers satisfactory performance."
        },
        "status": "active",
        "suitability": {
          "sme": true
        },
        "value": {
          "amount": 300000,
          "amountGross": 360000,
          "currency": "GBP"
        }
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "open",
    "procurementMethodDetails": "Open procedure",
    "status": "active",
    "submissionMethodDetails": "https://procontract.due-north.com/Advert?advertId=d32c4542-afbf-f011-813a-005056b64545\nPlease email procurement@md.catapult.org.uk if you have any issues accessing.",
    "submissionTerms": {
      "electronicSubmissionPolicy": "allowed",
      "languages": [
        "en"
      ]
    },
    "tenderPeriod": {
      "endDate": "2025-12-09T16:00:00Z"
    },
    "title": "A Health Economic Evaluation Framework And Bespoke Analysis For AMR Diagnostic Technologies",
    "value": {
      "amount": 300000,
      "amountGross": 360000,
      "currency": "GBP"
    }
  }
}